These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11975794)
61. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors. Mouillac B; Mendre C Handb Exp Pharmacol; 2018; 245():63-83. PubMed ID: 28939971 [TBL] [Abstract][Full Text] [Related]
62. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). Schrier RW N Engl J Med; 1988 Oct; 319(16):1065-72. PubMed ID: 3050518 [No Abstract] [Full Text] [Related]
63. [Vasopressin type 2 receptor mutations in congenital diabetes insipidus]. Tsukaguchi H; Matsubara H; Inada M Nihon Rinsho; 1998 Jul; 56(7):1848-55. PubMed ID: 9702064 [TBL] [Abstract][Full Text] [Related]
64. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Serradeil-Le Gal C; Wagnon J; Valette G; Garcia G; Pascal M; Maffrand JP; Le Fur G Prog Brain Res; 2002; 139():197-210. PubMed ID: 12436936 [TBL] [Abstract][Full Text] [Related]
66. Molecular mechanisms and drug development in aquaporin water channel diseases: molecular mechanism of water channel aquaporin-2 trafficking. Noda Y; Sasaki S J Pharmacol Sci; 2004 Nov; 96(3):249-54. PubMed ID: 15539762 [TBL] [Abstract][Full Text] [Related]
67. Aquaporin-2, a vasopressin-sensitive water channel, and nephrogenic diabetes insipidus. Kuwahara M Intern Med; 1998 Feb; 37(2):215-7. PubMed ID: 9550615 [TBL] [Abstract][Full Text] [Related]
68. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra). Bouley R; Pastor-Soler N; Cohen O; McLaughlin M; Breton S; Brown D Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1103-12. PubMed ID: 15644488 [TBL] [Abstract][Full Text] [Related]